Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CEO and President

SVP, Chief Operating Officer

SVP, Chief Legal Officer

SVP, Chief Medical Officer

Chief Commercial Officer

Chief Accounting Officer

SVP, CFO and Treasurer

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-29	Premium	sold	Premium	Premium	Premium	CEO and President
2024-02-29	Premium	sold	Premium	Premium	Premium	SVP, Chief Operating Officer
2024-02-29	Premium	sold	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-02-29	Premium	sold	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	SVP, Chief Operating Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	CEO and President
2024-02-01	Premium	sold	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-01	Premium	sold	Premium	Premium	Premium	CEO and President
2024-01-31	Premium	acquired	Premium	Premium	Premium	CEO and President
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	SVP, Chief Operating Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	SVP, CFO and Treasurer
2023-08-25	Premium	sold	Premium	Premium	Premium	SVP, Chief Medical Officer
2023-07-31	Premium	acquired	Premium	Premium	Premium	SVP, CFO and Treasurer
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-

AKBA - Akebia Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for AKBA